Toshiba launches CAC scoring for Aquilion
Toshiba America Medical Systems has introduced a coronary artery calcium scoring (CACS) package for its helical CT system, Aquilion. The package includes Toshiba’s FDA-cleared ECG-Gating System and Minneapolis, MN-based Vital Images’ Vitrea
Toshiba America Medical Systems has introduced a coronary artery calcium scoring (CACS) package for its helical CT system, Aquilion. The package includes Toshibas FDA-cleared ECG-Gating System and Minneapolis, MN-based Vital Images Vitrea visualization package, with the VScore calcium scoring option, which Toshiba has licensed. Toshibas CACS program first collects a 0.3-second partial scan with ECG-Gating System on Aquilion, reducing motion and artifacts. VScore is then used to evaluate a patients level and volume of arterial calcium.
The package is Toshibas latest offering in a series of CT upgrades. In September 1998, it introduced Aquilion, almost concurrently with GEs launch of its multislice CT LightSpeed QX/i scanner (SCAN 9/16/98). A few months later, the Tustin, CA, company launched Asteion, a lower priced scanner line that also supports multislice imaging, at the European Congress of Radiology in Vienna (SCAN 3/3/99).
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
